N. Turner and R. Grose, Fibroblast growth factor signalling: from development to cancer, Nature Reviews Cancer, vol.351, issue.2, pp.116-145, 2010.
DOI : 10.1038/nrc2780

R. Goetz and M. Mohammadi, Exploring mechanisms of FGF signalling through the lens of structural biology, Nature Reviews Molecular Cell Biology, vol.126, issue.3, pp.166-80, 2013.
DOI : 10.1021/bi011000u

E. Haugsten, A. Wiedlocha, and S. Olsnes, Roles of Fibroblast Growth Factor Receptors in Carcinogenesis, Molecular Cancer Research, vol.8, issue.11, pp.1439-52, 2010.
DOI : 10.1158/1541-7786.MCR-10-0168

A. Brooks, E. Kilgour, and P. Smith, Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer, Clinical Cancer Research, vol.18, issue.7, pp.1855-62, 2012.
DOI : 10.1158/1078-0432.CCR-11-0699

C. Warzecha, T. Sato, and B. Nabet, ESRP1 and ESRP2 Are Epithelial Cell-Type-Specific Regulators of FGFR2 Splicing, Molecular Cell, vol.33, issue.5, pp.591-601, 2009.
DOI : 10.1016/j.molcel.2009.01.025

T. Shirakihara, K. Horiguchi, and K. Miyazawa, TGF-?? regulates isoform switching of FGF receptors and epithelial-mesenchymal transition, The EMBO Journal, vol.119, issue.4, pp.783-95, 2011.
DOI : 10.1038/emboj.2010.351

S. Feng, F. Wang, and A. Matsubara, Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells, Cancer Res, vol.58, pp.1509-1523, 1997.

Y. Zhang, H. Wang, and S. Toratani, Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis, Proceedings of the National Academy of Sciences, vol.98, issue.20, pp.11336-11376, 2001.
DOI : 10.1073/pnas.191377098

H. Zur-hausen, Papillomaviruses and cancer: from basic studies to clinical application, Nature Reviews Cancer, vol.2, issue.5, pp.342-50, 2002.
DOI : 10.1038/nrc798

C. Moody and L. Laimnins, Human papillomavirus oncoproteins: pathways to transformation, Nature Reviews Cancer, vol.367, issue.8, pp.550-60, 2010.
DOI : 10.1038/nrc2886

A. Venuti, F. Paolini, and L. Nasir, Papillomavirus E5: the smallest oncoprotein with many functions, Molecular Cancer, vol.10, issue.1, p.140, 2011.
DOI : 10.1186/1476-4598-10-140

F. Belleudi, L. Leone, and V. Purpura, HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic, Oncogene, vol.98, issue.50, pp.4963-76, 2011.
DOI : 10.1038/onc.2011.203

V. Purpura, F. Belleudi, and S. Caputo, HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells, FGFR2b interplay in differentiating epithelial cells, pp.192-205, 2013.
DOI : 10.18632/oncotarget.803
URL : https://hal.archives-ouvertes.fr/pasteur-01053842

P. Boukamp, R. Petrussevska, and D. Breitkreutz, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line, The Journal of Cell Biology, vol.106, issue.3, pp.761-71, 1988.
DOI : 10.1083/jcb.106.3.761

I. Oelze, J. Kartenbeck, and K. Crusius, Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line, J Virol, vol.69, pp.4489-94, 1995.

M. Stanley, H. Browne, and M. Appleby, Properties of a non-tumorigenic human cervical keratinocyte cell line, International Journal of Cancer, vol.119, issue.4, pp.672-76, 1989.
DOI : 10.1002/ijc.2910430422

M. Pett, W. Alazawi, and I. Roberts, Acquisition of High-Level Chromosomal Instability Is Associated with Integration of Human Papillomavirus Type 16 in Cervical Keratinocytes, Cancer Research, vol.64, issue.4, pp.1359-68, 2004.
DOI : 10.1158/0008-5472.CAN-03-3214

E. Gray, M. Pett, and D. Ward, In vitro Progression of Human Papillomavirus 16 Episome-Associated Cervical Neoplasia Displays Fundamental Similarities to Integrant-Associated Carcinogenesis, Cancer Research, vol.70, issue.10, pp.4081-91, 2010.
DOI : 10.1158/0008-5472.CAN-09-3335

G. Cardinali, S. Ceccarelli, and D. Kovacs, Keratinocyte Growth Factor Promotes Melanosome Transfer to Keratinocytes, Journal of Investigative Dermatology, vol.125, issue.6, pp.1190-1199, 2005.
DOI : 10.1111/j.0022-202X.2005.23929.x
URL : http://doi.org/10.1111/j.0022-202x.2005.23929.x

S. Raffa, L. Leone, and C. Scrofani, Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion, Histochemistry and Cell Biology, vol.23, issue.2, pp.251-69, 2012.
DOI : 10.1007/s00418-012-0947-y
URL : https://hal.archives-ouvertes.fr/pasteur-00961698

G. Ashrafi, M. Haghshenas, and B. Marchetti, E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I, International Journal of Cancer, vol.72, issue.2, pp.276-83, 2005.
DOI : 10.1002/ijc.20558

J. Oh, S. Kim, and Y. Lee, Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells, Carcinogenesis, vol.30, issue.1, pp.141-150, 2009.
DOI : 10.1093/carcin/bgn236

D. French, F. Belleudi, and M. Mauro, Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway, Molecular Cancer, vol.12, issue.1, p.38, 2013.
DOI : 10.1128/JVI.06243-11
URL : https://hal.archives-ouvertes.fr/pasteur-01053844

C. Warzecha, S. Shen, and Y. Xing, The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events, RNA Biology, vol.6, issue.5, pp.546-62, 2009.
DOI : 10.4161/rna.6.5.9606

K. Horiguchi, K. Sakamoto, and D. Koinuma, TGF-?? drives epithelial-mesenchymal transition through ??EF1-mediated downregulation of ESRP, Oncogene, vol.117, issue.26, pp.3190-201, 2012.
DOI : 10.1038/onc.2011.493

K. Hellner, J. Mar, and F. Fang, HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition, Virology, vol.391, issue.1, pp.57-63, 2009.
DOI : 10.1016/j.virol.2009.05.036

Y. Jung, I. Kato, and H. Kim, A novel function of HPV16-E6/E7 in epithelial???mesenchymal transition, Biochemical and Biophysical Research Communications, vol.435, issue.3, pp.339-383, 2013.
DOI : 10.1016/j.bbrc.2013.04.060

J. Diaz-chavez, R. Hernandez-pando, and P. Lambert, Down-regulation of transforming growth factor-?? type II receptor (TGF-??RII) protein and mRNA expression in cervical cancer, Molecular Cancer, vol.7, issue.1, p.3, 2008.
DOI : 10.1186/1476-4598-7-3

B. Peghini, D. Abdalla, and A. Barcelos, Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia, Human Immunology, vol.73, issue.9, pp.920-946, 2012.
DOI : 10.1016/j.humimm.2012.06.003

S. Kowli, R. Velidandla, and K. Creek, TGF-?? regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes, Virology, vol.447, issue.1-2, pp.63-73, 2013.
DOI : 10.1016/j.virol.2013.08.034

D. Greco, N. Kivi, and K. Qian, Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs, PLoS ONE, vol.280, issue.7, p.21646, 2011.
DOI : 10.1371/journal.pone.0021646.s005

S. Barbaresi, M. Cortese, and J. Quinn, Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain, Journal of General Virology, vol.91, issue.2, pp.521-551, 2010.
DOI : 10.1099/vir.0.016295-0

F. Fehrmann and L. Laimins, Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation, Oncogene, vol.22, issue.33, pp.5201-5208, 2003.
DOI : 10.1038/sj.onc.1206554